{
    "clinical_study": {
        "@rank": "98975", 
        "acronym": "OPTIMISE", 
        "arm_group": {
            "arm_group_label": "Patients with diabetes type 2"
        }, 
        "brief_summary": {
            "textblock": "OPTIMISE-CEEMEA is a multinational, multi-centre, observational, prospective study which\n      will include patients suffering from diabetes type 2, treated or untreated, insulin\n      dependent or not insulin dependent.\n\n      In this study we aim to explore at a primary care level whether the use of benchmarking\n      against a set of guideline-based reference values on a patient basis, may improve quality of\n      patient care, in particular control of diabetes, lipids and blood pressure."
        }, 
        "brief_title": "OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus, Non-Insulin-Dependent", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects suffering from diabetes type 2,\n\n          -  treated or untreated,\n\n          -  insulin dependent or not insulin dependent  Able to read and send SMS (if SMS\n             applicable)\n\n        Exclusion Criteria:\n\n          -  Type 1 diabetes Pregnancy diabetes\n\n          -  Hospitalization at the moment of enrollment in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with diabetes type 2"
            }
        }, 
        "enrollment": {
            "#text": "733", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694758", 
            "org_study_id": "NIS-CME-XXX-2012/1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Benchmarking could improve quality of patient care", 
            "ESC and ATP III Guidelines"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Blagoevgrad", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pleven", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plovdiv", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alexandria", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brasov", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucuresti", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cluj", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Constanta", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galati", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Giurgiu", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iasi", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oradea", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pitesti", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ploiesti", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Satu Mare", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tg Jiu", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tg Mures", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Timisoara", 
                        "country": "Romania"
                    }, 
                    "name": "Research Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Bulgaria", 
                "Romania"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA (OPTIMISE)", 
        "overall_official": {
            "affiliation": "University of Medicine and Pharmacy Carol Davila, Bucharest, Romania", 
            "last_name": "Dan Isacoff, ASSOC. PROF.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Romania: National Medicine and Medical Devices Agency", 
                "Bulgaria: Bulgarian Drug Agency"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To investigate whether the use of benchmarking could improve quality of patient care, in particular the control of diabetes, lipids and blood pressure, expressed as the percentage of patients in the benchmarking group achieving pre-set targets for HbA1c1", 
            "measure": "Percentage of patients in the benchmarking group achieving pre-set targets for HbA1c1", 
            "safety_issue": "No", 
            "time_frame": "after 12 months of follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694758"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To investigate whether the use of benchmarking could improve quality of patient care, in particular the control of diabetes, lipids and blood pressure", 
                "measure": "Quality of patient care improvement, in particular the control of diabetes, lipids and blood pressure", 
                "safety_issue": "No", 
                "time_frame": "after 12 months of follow-up versus baseline"
            }, 
            {
                "description": "To follow up evolution markers of preventive screening; retinopathy, neuropathy, dietary counseling, smoking habits, BMI, waist circumference, physical activity", 
                "measure": "Markers of preventive screening", 
                "safety_issue": "No", 
                "time_frame": "after 12 months of follow-up versus baseline"
            }, 
            {
                "description": "To investigate the LDL cholesterol parameter of the primary and secondary objectives according to ATP III guidelines", 
                "measure": "The LDL cholesterol parameter of the primary and secondary objectives according to ATP III guidelines", 
                "safety_issue": "No", 
                "time_frame": "after 12 months of follow-up versus baseline"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}